Marcin Okrój

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Helicobacter Pylori

Diffuse Large B Cell Lymphoma

Candida Albicans

Chronic Lymphocytic Leukemia

Top Venues

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Alicja Kuźniewska, Alan Majeranowski, Sara Henry, Daria Kowalska, Grzegorz Stasilojc, Aleksandra Urban, Jan M Zaucha, Marcin Okrój
The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. Cancers 16 (1) (2023)
Alicja Kuźniewska, Alan Majeranowski, Sara Henry, Daria Kowalska, Grzegorz Stasilojc, Aleksandra Urban, Jan M Zaucha, Marcin Okrój
The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. Cancers 16 (1) (2023)
Aleksandra Urban, Alan Majeranowski, Grzegorz Stasilojc, Patrycja Koszałka, Anna Felberg, Michał Taszner, Jan M Zaucha, Marcin Okrój
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies. Cancers 14 (5) (2022)
Anna Felberg, Aleksandra Urban, Anna Borowska, Grzegorz Stasiłojć, Michał Taszner, Andrzej Hellmann, Anna Maria Blom, Marcin Okrój
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics. Cancer immunology, immunotherapy : CII 68 (4) (2019)